P.J. Flynn, M.D. Named East Metro GI Cancer Lead

Minnesota Oncology announced that oncologist P.J. Flynn, M.D., will be leading the practice’s GI (gastrointestinal) Cancer program in the East Metro.

{image_1}Dr. P.J. Flynn has been a leader in cancer care in the Twin Cities for decades, said Dean Gesme, MD. “He is an excellent and compassionate physician, an outstanding teacher, and a leader in cutting-edge research.”

Gastro-Intestinal (GI) cancer is a term for the group of cancers that affect the digestive system. This includes cancers of the esophagus, gallbladder, liver, pancreas, stomach, small intestine, bowel (large intestine or colon and rectum), and anus. Because GI cancer is the most common form of cancer, Minnesota Oncology believes that this leadership role is important.

As Minnesota Oncology’s GI Oncology lead physician in the East Metro, Dr. Flynn will be participating in multidisciplinary efforts with gastroenterologists, colon and rectal surgeons, and other specialists in the East Metro and will work closely with Allina Health, including Virginia Piper Cancer Institute.

“I look forward to continuing my close work with other area specialists to provide the best collaborative care possible for patients diagnosed with GI cancers,” said Dr. Flynn, who practices out of Minnesota Oncology’s Woodbury clinic location.

Dr. Flynn is widely recognized for his clinical research achievements – particularly serving for 30 years as the principal investigator for the National Cancer Institute Grant Funded Metro Clinical Community Oncology Project (CCOP). He has received numerous honors and accolades over the years, most recently being recognized with the 2016 Charles Bolles Bolles-Rogers Award which is given annually to an outstanding physician by the Twin Cities Medical Society Foundation.

Dr. P.J. Flynn can be reached by contacting Minnesota Oncology’s Woodbury Clinic at 651-735-7414.




Recent Posts

November 30, 2022

Your healthcare provider may recommend additional screening to monitor your small lung nodule and watch for growth over time.

November 23, 2022

Lung cancer is the second most common type of cancer and the leading cause of cancer death in the U.S. Studies show that lung cancer screening reduces the risk of dying from the disease.

November 16, 2022

The American Cancer Society has hosted the Great American Smokeout on the third Thursday of November for more than 40 years.